Novartis Ranks #10 in 25 Health Brand Campaigns That Redefined Marketing

Part of the 25 Health Brand Campaigns That Redefined Digital Marketing index.

Novartis ranks #10 in 25 Health Brand Campaigns That Redefined Digital Marketing, a survey of roughly 25 influential health-related digital marketing campaigns published by Everything-PR. The company earns its place in the countdown for its "Unblocked" heart health awareness campaign, which the index highlights for using simple, visual metaphors to explain complex conditions. Novartis appears among a field of hospital systems, pharma companies, mental health apps, and retail health brands, positioned just ahead of Headspace at #11 and among peers including Pfizer and Johnson & Johnson.

What the Index Measures

25 Health Brand Campaigns That Redefined Digital Marketing identifies approximately 25 influential health-related digital marketing campaigns spanning hospital systems, pharma companies, mental health apps, retail health brands, and fitness and wearable brands. The index describes each campaign's approach and groups the brands into thematic clusters. No numeric scoring or ranking methodology is described; brands are presented in a countdown-style list grouped by category. Novartis is placed at #10 in that countdown.

Why Novartis Ranks #10

Novartis's position in the index rests on its "Unblocked" campaign, focused on heart health awareness. The index characterizes the campaign's approach as using simple, visual metaphors to explain complex conditions. That approach, translating clinical complexity into accessible imagery, is the specific attribute the index attributes to Novartis in placing it within the countdown.

Novartis sits alongside other pharma companies recognized in the same index, including Pfizer at both #6 and #7, Johnson & Johnson at #8, and AbbVie at #9. Its #10 placement puts it at the boundary between the pharma cluster and the mental health app cluster that follows, which opens with Headspace at #11 and Calm at #12.

The "Unblocked" campaign fits a pattern the index calls out across its featured brands: the shift from statistics to stories, and from abstractions to faces. According to the index, the marketing that stood out made health relatable, with stories replacing statistics and faces replacing abstractions. Novartis's use of visual metaphor to explain a complex condition aligns with that theme.

Inside Novartis's Corporate Positioning

Beyond the campaign cited in the index, Novartis describes itself as a company that has, in its own words, "pursued scientific breakthroughs for one purpose: people" for more than 250 years, and 30 years as Novartis. The company states that it takes on challenges in healthcare and turns innovations into medicines.

Novartis's recent corporate communications reflect an active product and regulatory pipeline. In July 2026, the company announced it had received European Commission approval for Itvisma for spinal muscular atrophy. In June 2026, Novartis presented RemIND data at EAACI showing Rhapsido's potential as a first targeted therapy for chronic inducible urticaria, and reported that its delpacibart braxlosiran Phase I/II study in facioscapulohumeral muscular dystrophy met its primary biomarker endpoint. The company has also announced an expansion of its manufacturing and R&D facilities in the United States.

These corporate signals sit outside the index's scope, which is limited to the "Unblocked" heart health awareness campaign. They provide context on how Novartis positions itself publicly, but the index's recognition is specific to that single campaign and its visual-metaphor approach.

Where Novartis Sits in the Broader Health Marketing Story

The index frames its featured campaigns around several shared patterns. Two are especially relevant to how Novartis is characterized. First, the index observes that the featured brands made health relatable, with stories replacing statistics and faces replacing abstractions. Second, it notes that the campaigns embraced digital behavior through short-form video, social engagement, and app integration. Novartis's inclusion rests on the first of these: explaining a complex condition through simple visual metaphor.

The index also observes a broader shift in how patients relate to health brands, stating that patients are no longer passive audiences and are instead users, contributors, and advocates. Within that framing, Novartis's "Unblocked" campaign is presented as an example of translating clinical complexity into something a general audience can grasp.

Novartis shares the countdown with brands across categories that the index treats as distinct clusters, from hospital systems led by Cleveland Clinic at #1 and #2 and Mayo Clinic at #3, through the pharma group, to mental health apps, retail health brands such as CVS Health at #16 and Walgreens at #17, and fitness and wearable brands including Nike at #15, Apple at #21, and Peloton at #23. The list closes with the WHO at #24 and the NHS at #25.

At #10, Novartis is recognized for a single campaign attribute the index makes explicit: using simple, visual metaphors to explain complex conditions. Its placement reflects that specific approach to heart health awareness rather than a numeric score, since the index applies no numeric scoring or ranking methodology. Going into any future refresh, Novartis's standing in this kind of survey rests on how its campaigns continue to translate complex conditions into accessible communication.

Work with Everything-PR

Have a question about this research, or want to discuss your brand's coverage? Get in touch with our team.

Contact Us →